EPISODE · Apr 23, 2025 · 4 MIN
FDA Issues CRL to Regeneron for Eylea HD Extended Dosing
from Eyewire News: The Podcast · host Eyewire News
The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
FDA Issues CRL to Regeneron for Eylea HD Extended Dosing
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m